bromodeoxyuridine has been researched along with Carcinoma, Epidermoid in 156 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 31 (19.87) | 18.7374 |
| 1990's | 71 (45.51) | 18.2507 |
| 2000's | 42 (26.92) | 29.6817 |
| 2010's | 10 (6.41) | 24.3611 |
| 2020's | 2 (1.28) | 2.80 |
| Authors | Studies |
|---|---|
| Kirihata, M; Masunaga, SI; Ono, K; Sakurai, Y; Sanada, Y; Suzuki, M; Takata, T; Tanaka, H | 1 |
| Abe, Y; Houri, A; Kurihara, M; Miyamoto, S; Mukudai, Y; Nara, M; Shimane, T; Shirota, T; Watanabe, M | 1 |
| Baumann, M; Brüchner, K; Gurtner, K; Helbig, L; Hess-Stumpp, H; Koi, L; Pruschy, M; Unterschemmann, K; Yaromina, A; Zips, D | 1 |
| Guo, S; He, X; Lan, H; Lan, T; Li, J; Li, W; Qi, C; Wang, L; Wei, P; Yang, Y; Ye, J; Zhang, Q | 1 |
| Cao, W; Chen, W; Liu, J; Xu, L; Zhang, C | 1 |
| Ando, K; Furusawa, Y; Hirayama, R; Koike, S; Masunaga, S; Ono, K; Uzawa, A | 2 |
| Ando, K; Hirayama, R; Kashino, G; Kinashi, Y; Koike, S; Liu, Y; Masunaga, S; Ono, K; Suzuki, M; Uzawa, A | 1 |
| Danaher, RJ; Greenberg, RN; Kaetzel, CS; Miller, CS; Roland, AT; Wang, C | 1 |
| Ando, K; Hirayama, R; Kashino, G; Kinashi, Y; Koike, S; Liu, Y; Masunaga, S; Ono, K; Suzuki, M; Takata, T; Tanaka, H; Uzawa, A | 1 |
| Achouri, Y; Blanpain, C; Lapouge, G; Michaux, C; Sotiropoulou, PA; Vokaer, B; Youssef, KK | 1 |
| Baumann, M; Eicheler, W; Krause, M; Menegakis, A; Thames, HD; Yaromina, A | 1 |
| Murasaki, T; Nakanishi, M; Ogawa, K; Shirai, T; Sugiura, S | 1 |
| Chen, XF; Ge, LH; Miao, CC; Sun, Z; Tian, ZC; Zhang, XY | 1 |
| Bernard, JJ; Conney, AH; Li, T; Lin, Y; Lou, YR; Lu, YP; Nghiem, P; Peng, QY; Shapses, S; Shih, WJ; Wagner, GC | 1 |
| Bussink, J; Denekamp, J; Kaanders, JH; Ljungkvist, AS; Rijken, PF; van der Kogel, AJ | 1 |
| Dobrowsky, E; Dobrowsky, W; Wilson, GD | 1 |
| Fukushima, S; Kaneko, M; Kinoshita, A; Kinoshita, H; Morimura, K; Nishikawa, T; Ogawa, M; Osugi, H; Salim, EI | 1 |
| Hori, H; Kinashi, Y; Masunaga, S; Nagasawa, H; Nagata, K; Ohnishi, K; Ohnishi, T; Ono, K; Suzuki, M; Takahashi, A; Uto, Y | 1 |
| Baker, JH; Burston, HE; Huxham, LA; Kyle, AH; Minchinton, AI | 1 |
| Chapman, W; Fykes, AW; Hill, RP; Juvet, S; Levin, W; Manchul, LA; Milosevic, M; Pintilie, M; Tsang, RW; Wong, CS | 1 |
| Bemis, D; Gudas, LJ; Knudsen, B; Tang, XH; Tickoo, S | 1 |
| Kawada, K; Kawano, T; Miyake, S; Nagai, K; Nakajima, Y; Nishikage, T; Ogiya, K; Tanaka, K; Toukairin, Y | 1 |
| Kinash, Y; Maruhashi, A; Masunaga, S; Nagata, K; Ono, K; Sakurai, Y; Suzuki, M | 1 |
| Barnes, LM; Popa, C; Saunders, NA; Serewko-Auret, MM; Smith, L; Wong, CF | 1 |
| Kitagawa, M; Kitajima, S; Kudo, Y; Miyauchi, M; Ogawa, I; Takata, T | 1 |
| Hori, H; Kinashi, Y; Masunaga, S; Nagasawa, H; Nagata, K; Ono, K; Suzuki, M; Uto, Y | 1 |
| Kamida, A; Kato, I; Nagata, K; Obayashi, S; Ono, K; Sakurai, Y; Suzuki, M; Yura, Y | 1 |
| Fischer, SM; He, G; Hwang, DH; Sung, YM | 1 |
| Hori, H; Kinashi, Y; Maruhashi, A; Masunaga, S; Nagasawa, H; Nagata, K; Ono, K; Sakurai, Y; Suzuki, M; Uto, Y | 1 |
| Kasaoka, S; Kinashi, Y; Maruhashi, A; Maruyama, K; Masunaga, S; Nagata, K; Nigg, D; Ono, K; Sakurai, Y; Suzuki, M | 1 |
| Alagbala, AA; Foster, BA; Johnson, CS; Posner, GH; Trump, DL | 1 |
| Hankins, JL; McLaughlin, PJ; Verderame, MF; Zagon, IS | 1 |
| Hass, HG; Kaiser, S; Nehls, O; Schmidt, A | 1 |
| Kashino, G; Kinashi, Y; Masunaga, S; Nagata, K; Ono, K; Suzuki, M | 1 |
| Ando, K; Furusawa, Y; Hirayama, R; Kashino, G; Kinashi, Y; Koike, S; Maruhashi, A; Masunaga, S; Nagata, K; Ono, K; Sakurai, Y; Suzuki, M; Tanaka, H; Uzawa, A | 1 |
| Bagshaw, MA; Doggett, RL; Kaplan, HS; Nelsen, TS; Smith, KC | 1 |
| Tchao, R | 1 |
| Rieber, M; Rieber, MS | 1 |
| Miyata, M; Morita, M | 1 |
| Angelopoulos, AP; Bazopoulou-Kyrkanidou, E; Garas, J; Zervou-Valvi, F | 1 |
| Itoh, T; Takahashi, H; Yamamoto, Y | 2 |
| Ando, N; Kitagawa, Y; Kitajima, M; Ozawa, S; Ueda, M | 1 |
| Caldarelli, DD; Coon, JS; Hutchinson, J; Kotelnikov, VM; LaFollette, S; Panje, W; Preisler, HD; Taylor, S | 1 |
| Blessing, M; Hogan, BL; King, LE; Nanney, LB | 1 |
| Siegfried, JM; Singh-Kaw, P; Zarnegar, R | 1 |
| Chakraborty, RN; Chatterjee, R; Mukhopadhyay, D | 1 |
| Banerjee, D; Fyles, AW; Kirkbride, P; Levin, W; Manchul, LA; Milosevic, MF; Pintilie, M; Rawlings, GA; Tsang, RW; Wilson, GD | 1 |
| Itamochi, H; Kanamori, Y; Kigawa, J; Minagawa, Y; Terakawa, N | 1 |
| Healy, E; Morley, A; Rees, JL; Smith, MD; Thompson, V | 1 |
| Daley, FM; Dische, S; Richman, PI; Robinson, B; Ross, DA; Saunders, MI; Wilson, GD | 1 |
| Bentzen, SM; Høyer, M; Overgaard, J; Salling, LN | 1 |
| Caslin, AW; Cooke, LD; Cooke, TG; Forster, G; Jones, AS; Roland, NJ | 1 |
| Abe, M; Akaboshi, M; Akuta, K; Ando, K; Koike, S; Masunaga, S; Ono, K | 1 |
| Matsuoka, K; Nishikawa, T; Nishimura, Y; Okano, H; Tanaka, A; Tsutsui, J; Wada, S; Wato, M | 1 |
| Cooke, LD; Cooke, TG; Forster, G; Jones, AS; Stell, PM | 1 |
| Armand, JP; Bosq, J; Bourhis, J; Eschwege, F; Janot, F; Luboinski, B; Malaise, EP; Wibault, P; Wilson, G | 1 |
| Armand, JP; Bosq, J; Bourhis, J; Bressac, B; Dendale, R; Janin, N; Leridant, AM; Luboinski, B; Talbot, M; Wilson, GD | 1 |
| Fujita, A; Horii, K; Matsuoka, K; Nagao, Y; Nishikawa, T; Okano, H; Tanaka, A; Tsujimoto, K; Wato, M | 1 |
| Begg, AC; Hofland, I; Kummermehr, J; Schultz-Hector, S; Sund, M | 1 |
| Bacigalupo, A; Barra, S; Corvò, R; Geido, E; Giaretti, W; Margarino, G; Orecchia, R; Sanguineti, G; Vitale, V | 1 |
| Bosq, J; Bourhis, J; Chavaudra, N; Eschwege, F; Janot, F; Luboinski, B; Malaise, EP; Wibault, P; Wilson, G | 1 |
| Abe, Y; Aoki, M; Kaimori, M; Mariya, Y; Takekawa, S; Tarusawa, N | 1 |
| Inoue, I; Itoh, T; Saka, T; Takahashi, H; Yamamoto, Y | 1 |
| Gluckman, JL; Hirano, T; Zitsch, RP | 2 |
| Akanuma, A; Aoki, Y; Hasezawa, K; Karasawa, K; Muta, N; Nakagawa, K; Onogi, Y; Sakata, K; Sasaki, Y; Terahara, A | 1 |
| Dische, S; Saunders, MI; Wilson, GD | 1 |
| Hillebrandt, S; Streffer, C; Zölzer, F | 1 |
| Inokuchi, T; Sano, K; Uehara, M | 1 |
| Daley, FM; Dische, S; Joiner, B; Martindale, CA; Richman, PI; Robinson, BM; Saunders, MI; Wilson, GD | 1 |
| Attal, P; Bobin, S; Bosq, J; Bourhis, J; Dendale, R; Eschwege, F; Fortin, A; Hill, C; Janot, F; Luboinski, B; Malaise, EP; Marandas, P; Schwaab, G; Wibault, P; Wilson, G | 1 |
| Cichocka, A; Gasińska, A; Pudełek, J; Skołyszewski, J; Urbański, K; Zabagło, L | 1 |
| Antognoni, P; Barbera, F; Bardelli, D; Bignardi, M; Bossi, A; Cazzaniga, LF; Danova, M; Giordano, M; Poli, AM; Rampello, G; Richetti, A; Soatti, C | 1 |
| Baldetorp, B; Bendahl, PO; Fadeel, IA; Johansson, MC; Oredsson, SM | 1 |
| Hirose, Y; Ino, N; Kawamori, T; Miyata, H; Mori, H; Ohnishi, M; Tanaka, T; Yamahara, J; Yoshimi, N | 1 |
| Abe, M; Akaboshi, M; Hiraoka, M; Kinashi, Y; Masunaga, S; Nishimura, Y; Ono, K; Suzuki, M; Takagaki, M | 1 |
| Biesaga, B; Gasińska, A; Kolodziejski, L | 1 |
| Foley, JF; Kim, TW; Maronpot, RR; Porter, KL; Smart, RC | 1 |
| Akaboshi, M; Kawai, K; Kinashi, Y; Masunaga, S; Ono, K; Suzuki, M; Takagaki, M | 1 |
| Akaboshi, M; Hori, H; Kinashi, Y; Masunaga, S; Ono, K; Shibata, T; Suzuki, M; Takagaki, M | 1 |
| Conney, AH; Huang, MT; Lou, YR; Lu, YP; Xie, JG; Yen, P | 1 |
| Bussink, J; Kaanders, JH; Martindale, CA; Rijken, PF; van der Kogel, AJ | 1 |
| Akaboshi, M; Kinashi, Y; Kobayashi, T; Masunaga, S; Ono, K; Sakurai, Y; Suzuki, M; Takagaki, M | 5 |
| Nin, F | 1 |
| Wang, LD; Yang, CS; Zhou, Q | 1 |
| Hatakeyama, K; Hitomi, J; Kimura, T; Kusumi, E; Kuwabara, S; Nakagawa, S; Yamaguchi, K | 1 |
| Inokuchi, T; Pe, MB; Sano, K; Uehara, M | 1 |
| Hideshima, K; Inokuchi, T; Irie, A; Ma, G; Sano, K; Sekine, J; Uehara, M | 1 |
| Caldarelli, DD; Coon JS, IV; Griem, K; Haleem, A; Hutchinson, J; Kotelnikov, VM; Panje, W; Preisler, HD; Taylor S, IV | 1 |
| Bischoff, ED; Davies, PJ; Gregory, ML; Hayes, JS; Heyman, RA; Lamph, WW; Shalinsky, DR; Thomazy, V | 1 |
| Ishikawa, K; Iwasaki, T; Kati, S; Lackner, AA; Masegi, T; Ohta, J; Sakai, H; Yanai, T; Yoshida, K | 1 |
| Biesaga, B; Gasińska, A; Jakubowicz, J; Klimek, M; Urbański, K; Wilson, GD | 1 |
| Chapman, W; Fyles, AW; Li, Y; Pintilie, M; Rajaraman, MM; Tsang, RW; Wong, CS | 1 |
| Eisbruch, A; Johnston, CM; Lawrence, TS; Reynolds, KR; Roberts, JA; Robertson, JM; Tworek, J | 1 |
| Fyles, AW; Levin, W; Manchul, LA; Milosevic, M; Pintilie, M; Syed, A; Tsang, RW | 1 |
| Babich, H; Reisbaum, AG; Zuckerbraun, HL | 1 |
| Hori, H; Kasai, S; Kinashi, Y; Masunaga, SI; Nagasawa, H; Ono, K; Suzuki, M; Takagaki, M; Uto, Y | 1 |
| Brinkley, BR; Go, C; He, W; Huang, J; Li, P; Wang, XJ; Zhong, L | 1 |
| Ikeda, H; Inokuchi, T; Sano, K; Sekine, J; Uehara, M; Wang, ZL | 1 |
| Hori, H; Kasai, S; Kinashi, Y; Masunaga, S; Nagasawa, H; Ono, K; Suzuki, M; Takagaki, M; Uto, Y | 1 |
| Fowler, JF; Haustermans, K | 1 |
| Cvetkovska, E; Edström, S; Westin, T; Young, C | 1 |
| Lauer, G; Schimming, R | 1 |
| Hordijk, GJ; Kal, HB; Struikmans, H; van der Tweel, I | 1 |
| Jeon, SH; Jin, YJ; Lee, E; Son, YS; Yi, JY | 1 |
| Hori, H; Kinashi, Y; Masunaga, SI; Murayama, C; Nagasawa, H; Nishimura, Y; Ono, K; Sadahiro, S; Suzuki, M; Takagaki, M; Tsuchiya, I; Uto, Y | 1 |
| Hideshima, K; Inokuchi, T; Irie, A; Sano, K; Sekine, J; Uehara, M | 1 |
| Hori, H; Kinashi, Y; Kirihata, M; Kobayashi, T; Masunaga, SI; Nagasawa, H; Ono, K; Sakurai, Y; Takagaki, M; Uto, Y | 1 |
| Kinashi, Y; Kobayashi, T; Masunaga, S; Ono, K; Sakurai, Y; Suzuki, M; Takagaki, M | 1 |
| Flygare, P; Gustafsson, H; Sjöström, B; Wilson, GD; Zackrisson, B | 1 |
| Izumi, Y; Machigashira, M; Setoguchi, T; Yaegaki, K; Yamamoto, M; Yoshimori, M; Yotsumoto, Y | 1 |
| Asanami, S; Hirayama, T; Lian, SL; Nagai, T; Sakaizumi, K; Tomita, O | 1 |
| Miyakawa, K; Morita, M; Sato, Y | 1 |
| Bennett, MH | 1 |
| Kawamoto, K; Kumazawa, H; Kumazawa, T; Matsumura, H; Wada, Y; Yamashita, T | 1 |
| Baldetorp, B; Johansson, M; Källén, A; Killander, D; Oredsson, S; Wennerberg, J; Zätterström, UK | 1 |
| Hoshiya, T; Kato, T; Ogawa, K; Shirai, T; Tatematsu, M | 1 |
| Banks, WL; Chan, WM; Collins, JM; Frank, JL; Lawrence, W; McKinnon, JG | 1 |
| Bowie, G; Cooke, LD; Cooke, TG; Forster, G; Stanton, PD; Stell, PM | 1 |
| Bennett, MH; Dische, S; Laing, JH; Leslie, MD; Martindale, CA; O'Halloran, AE; Robinson, BM; Saunders, MI; Wilson, GD | 1 |
| Terry, NH; White, RA | 1 |
| Coptcoat, M; Rew, DA; Thomas, DJ; Wilson, GD | 1 |
| Bokhari, J; Hyams, D; Khan, S; Raza, A; Sheikh, Y; Yousuf, N | 1 |
| Edström, SS; Gustafsson, B; Lydén, E; Stein, H; Stenman, G; Westin, T | 1 |
| Hemmer, J | 1 |
| Goehde, W; Hemmer, J; Mauro, F; Salvati, F; Storniello, G; Teodori, L; Trinca, ML | 1 |
| Ackland, SP; Beckett, MA; Schilsky, RL; Weichselbaum, RR | 1 |
| Gasinska, A; Urbanski, K; Wilson, GD | 1 |
| Kawamoto, K; Kumazawa, T; Matsumura, H; Oka, S; Wada, Y; Yamashita, T | 1 |
| Hieda, S; Ishihara, M; Noguchi, M; Sawaguchi, K; Ueno, N; Yabushita, H | 1 |
| Abe, H; Kaku, T; Kanno, H; Nakade, O; Ogawa, A; Ohuchi, T; Okuyama, T | 1 |
| Hayata, Y; Morinaga, S; Shimosato, Y; Yoshida, K | 1 |
| Yoshinouchi, M | 1 |
| Cho, EK; Chung, CH; Lee, SS; Lee, TS; Park, JS | 1 |
| Hirama, T; Izutsu, T; Kagabu, T; Matsuda, M; Nishiya, I; Yoshizumi, N | 1 |
| Bennett, MH; Dische, S; McNally, NJ; Saunders, MI; Wilson, GD | 1 |
| Ensminger, WD; Johnson, NJ; Knol, JA; Knutsen, CA; Prieskorn, D; Stetson, PL; Terrio, P; Wagner, JG; Yang, ZM | 1 |
| Hanyu, F; Ide, H; Kobayashi, S; Muto, H; Nakagawa, M; Shimamura, Y; Takasaki, K; Tanaka, S; Yamada, A; Yamamoto, M | 1 |
| Carey, TE; Ensminger, WD; Maybaum, J; Shapira, A; Stetson, PL; Wagner, JG; Wollner, IS | 1 |
| Fukuda, K; Hachisuga, T; Hayashi, Y; Iwasaka, T; Sugimori, H | 1 |
| Matsumura, K; Sasaki, K; Shinozaki, F; Takahashi, M; Tsuji, T | 1 |
| Kärcher, H; Kärcher, KH; McNally, NJ; Pfragner, R; Wilson, G | 1 |
| Boothman, DA; Greer, S; Pardee, AB | 1 |
| Kawamoto, K; Kumazawa, T; Kuriyama, H; Matsumura, H; Oka, S; Wada, Y; Yamashita, T | 1 |
| Isobe, H; Ito, M; Kawakami, Y; Miyamoto, H; Mizuno, S | 1 |
| Bagshaw, MA; Goffinet, DR | 1 |
| Clarkson, BD; Duschinsky, R; Keller, O; Krakoff, IH; La Sala, E; Van Dyk, JJ | 1 |
| Koyama, Y; Matsutani, M; Sing, OK; Takakura, K | 1 |
| Cooper, GM | 1 |
| Higgins, ML; Leach, FR; Leach, KK; Melnykovych, G; Tillman, MC | 1 |
1 review(s) available for bromodeoxyuridine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Clinical use of radiation sensitizing agents.
Topics: Animals; Antimetabolites, Antineoplastic; Bleomycin; Bromodeoxycytidine; Bromodeoxyuridine; Bromouracil; Carcinoma, Squamous Cell; Dactinomycin; Dose-Response Relationship, Radiation; Floxuridine; Fluorouracil; Head and Neck Neoplasms; Humans; Hydroxyurea; Idoxuridine; Neoplasms; Neoplasms, Experimental; Radiation-Sensitizing Agents | 1974 |
7 trial(s) available for bromodeoxyuridine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
In vivo cell kinetic measurements in a randomized trial of continuous hyperfractionated accelerated radiotherapy with or without mitomycin C in head-and-neck cancer.
Topics: Analysis of Variance; Antibiotics, Antineoplastic; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Combined Modality Therapy; Head and Neck Neoplasms; Humans; Mitomycin; Neoplasm Staging; Ploidies; Radiation-Sensitizing Agents; Survival Analysis | 2003 |
Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.
Topics: Adenocarcinoma; Adult; Aged; Biopsy; Brachytherapy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Confidence Intervals; Disease-Free Survival; DNA, Neoplasm; Female; Flow Cytometry; Follow-Up Studies; Humans; Kinetics; Middle Aged; Mitotic Index; Neoplasm Staging; Prospective Studies; Quality Assurance, Health Care; Radiography; Radiotherapy; Radiotherapy Dosage; Regression Analysis; S Phase; Survival Rate; Time Factors; Treatment Failure; Uterine Neoplasms | 1995 |
Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control.
Topics: Actuarial Analysis; Adult; Age Factors; Aged; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Kinetics; Laryngeal Neoplasms; Male; Middle Aged; Mouth Neoplasms; Nasopharyngeal Neoplasms; Neoplasm Staging; Pharyngeal Neoplasms; Ploidies; Prognosis | 1993 |
In vivo measurement of the potential doubling time by flowcytometry in oropharyngeal cancer treated by conventional radiotherapy.
Topics: Aged; Bromodeoxyuridine; Carcinoma, Squamous Cell; Female; Flow Cytometry; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Prospective Studies; Survival Rate | 1993 |
Accelerated radiation therapy for locally advanced squamous cell carcinomas of the oral cavity and oropharynx selected according to tumor cell kinetics--a phase II multicenter study.
Topics: Adult; Aged; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cause of Death; DNA; Female; Humans; Male; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Survival Rate | 1996 |
Bromodeoxyuridine alternating with radiation for advanced uterine cervix cancer: a phase I and drug incorporation study.
Topics: Adenocarcinoma; Adult; Aged; Biopsy; Brachytherapy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Humans; Intestinal Mucosa; Middle Aged; Neoplasm Recurrence, Local; Radiation-Sensitizing Agents; Radiotherapy Dosage; Survival Rate; Uterine Cervical Neoplasms | 1999 |
Tissue-engineered mucosa graft for reconstruction of the intraoral lining after freeing of the tongue: a clinical and immunohistologic study.
Topics: Adult; Aged; Biomedical Engineering; Biopsy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Culture Techniques; Female; Histocytochemistry; Humans; Keratinocytes; Keratins; Male; Middle Aged; Mouth Floor; Mouth Mucosa; Mouth Neoplasms; Pilot Projects; Tongue; Vestibuloplasty | 2001 |
148 other study(ies) available for bromodeoxyuridine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
The impact of TP53 status of tumor cells including the type and the concentration of administered 10B delivery agents on compound biological effectiveness in boron neutron capture therapy.
Topics: Animals; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Sulfhydryl Compounds; Tumor Suppressor Protein p53 | 2023 |
Suprabasin enhances the invasion, migration, and angiogenic ability of oral squamous cell carcinoma cells under hypoxic conditions.
Topics: Animals; Antigens, Differentiation; Bromodeoxyuridine; Carcinoma, Squamous Cell; Caspase 3; Cell Line, Tumor; Cell Movement; Cell Proliferation; Head and Neck Neoplasms; Humans; Hypoxia; Mice; Mouth Neoplasms; Neoplasm Proteins; Squamous Cell Carcinoma of Head and Neck; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2023 |
Hypoxia-inducible factor pathway inhibition resolves tumor hypoxia and improves local tumor control after single-dose irradiation.
Topics: Amines; Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Nucleus; Dose Fractionation, Radiation; Electron Transport Complex I; Female; Heterografts; Humans; Hypoxia-Inducible Factor 1; Ki-67 Antigen; Male; Mice; Mice, Nude; Neoplasm Transplantation; Nitroimidazoles; Radiation Tolerance; Radiation-Sensitizing Agents; Random Allocation; Tumor Microenvironment | 2014 |
Slit2 promotes tumor growth and invasion in chemically induced skin carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Basement Membrane; Blood Vessels; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Collagen Type IV; Humans; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Confocal; Neoplasm Invasiveness; Nerve Tissue Proteins; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tumor Burden | 2014 |
Decreased expression of Kallmann syndrome 1 sequence gene (KAL1) contributes to oral squamous cell carcinoma progression and significantly correlates with poorly differentiated grade.
Topics: Bromodeoxyuridine; Carcinogenesis; Carcinoma, Squamous Cell; Cell Culture Techniques; Cell Cycle Checkpoints; Cell Differentiation; Cell Division; Cell Line, Tumor; Cell Proliferation; Cohort Studies; Disease Progression; Extracellular Matrix Proteins; Female; G1 Phase; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Silencing; Humans; Male; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Neoplasm Grading; Nerve Tissue Proteins; RNA, Small Interfering; Sincalide; Tumor Suppressor Proteins | 2015 |
The radiosensitivity of total and quiescent cell populations in solid tumors to 290 MeV/u carbon ion beam irradiation in vivo.
Topics: Animals; Bromodeoxyuridine; Carbon Radioisotopes; Carcinoma, Squamous Cell; Cell Survival; Dose-Response Relationship, Radiation; Female; Fluorescent Antibody Technique; Gamma Rays; Linear Energy Transfer; Mice; Mice, Inbred C3H; Radiation-Sensitizing Agents; Staining and Labeling; Time Factors; Tumor Stem Cell Assay | 2008 |
Responses of total and quiescent cell populations in solid tumors to carbon ion beam irradiation (290 MeV/u) in vivo.
Topics: Animals; Bromodeoxyuridine; Carbon; Carcinoma, Squamous Cell; Cell Proliferation; Cell Survival; Female; Fluorescent Antibody Technique; Gamma Rays; Linear Energy Transfer; Mice; Micronucleus Tests; Radiation Tolerance; Radiobiology; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2008 |
The effect of post-irradiation tumor oxygenation status on recovery from radiation-induced damage in vivo: with reference to that in quiescent cell populations.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Radiation; Female; Fluorescent Antibody Technique; Gamma Rays; Mice; Mice, Inbred C3H; Micronuclei, Chromosome-Defective; Neoplasms; Radiation Injuries; Radiation Tolerance | 2009 |
HIV protease inhibitors block oral epithelial cell DNA synthesis.
Topics: Analysis of Variance; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Line; Cell Proliferation; Cells, Cultured; DNA Replication; Dose-Response Relationship, Drug; Enzyme Assays; Epithelial Cells; HIV Protease Inhibitors; Humans; Keratinocytes; Mouth Mucosa; Tongue Neoplasms; Tumor Cells, Cultured | 2010 |
Influence of manipulating hypoxia in solid tumors on the radiation dose-rate effect in vivo, with reference to that in the quiescent cell population.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Carbon Radioisotopes; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Radiation; Female; Fluorescent Antibody Technique; Gamma Rays; Mice; Mice, Inbred C3H; Misonidazole; Niacinamide; Radiation Tolerance; Radiation-Sensitizing Agents; Tumor Cells, Cultured; Vitamin B Complex | 2010 |
Identifying the cellular origin of squamous skin tumors.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Lineage; DNA Primers; Epidermal Cells; Flow Cytometry; Hair Follicle; Integrases; Mice; Mice, Transgenic; Proto-Oncogene Proteins p21(ras); Reverse Transcriptase Polymerase Chain Reaction; Skin Neoplasms; Stem Cells | 2011 |
Residual DNA double strand breaks in perfused but not in unperfused areas determine different radiosensitivity of tumours.
Topics: Aged; Aged, 80 and over; Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Line, Tumor; DNA Breaks, Double-Stranded; Female; Histones; Humans; Hypopharyngeal Neoplasms; Male; Mice; Radiation Tolerance | 2011 |
Organ differences in the impact of p27(kip1) deficiency on carcinogenesis induced by N-methyl-N-nitrosourea.
Topics: Adenocarcinoma; Alkylating Agents; Animals; Antimetabolites; Body Weight; Bromodeoxyuridine; Carcinogens; Carcinoma, Squamous Cell; Cyclin-Dependent Kinase Inhibitor p27; Genotype; Immunohistochemistry; Lymphoma; Male; Methylnitrosourea; Mice; Mice, Knockout; Neoplasms; Organ Size; Organ Specificity | 2013 |
[Chemopreventive effect of boswellic acid and curcumin on 7,12-dimethyl benzanthracene-induced hamster cheek pouch carcinogenesis].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Bromodeoxyuridine; Carcinogenesis; Carcinogens; Carcinoma, Squamous Cell; Cheek; Cricetinae; Curcumin; Hyperplasia; Leukotriene B4; Male; Mesocricetus; Mouth Neoplasms; Precancerous Conditions; Random Allocation; Triterpenes | 2011 |
Surgical removal of the parametrial fat pads stimulates apoptosis and inhibits UVB-induced carcinogenesis in mice fed a high-fat diet.
Topics: Absorptiometry, Photon; Adipose Tissue; Animals; Apoptosis; Bromodeoxyuridine; Carcinoma, Squamous Cell; Caspase 3; Diet, High-Fat; Female; Immunohistochemistry; Keratoacanthoma; Lipectomy; Mice; Neoplasms, Radiation-Induced; Reverse Transcriptase Polymerase Chain Reaction; Ultraviolet Rays | 2012 |
Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Cell Hypoxia; Head and Neck Neoplasms; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous | 2002 |
High susceptibility of p53 knockout mice to esophageal and urinary bladder carcinogenesis induced by N, N-dibutylnitrosamine.
Topics: Alleles; Animals; Body Weight; Bromodeoxyuridine; Carcinogens; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Esophageal Neoplasms; Genes, p53; Genetic Predisposition to Disease; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Mutation; Nitrosamines; Organ Size; Point Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Sequence Analysis, DNA; Time Factors; Urinary Bladder Neoplasms | 2003 |
Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Hypoxia; Cisplatin; Combined Modality Therapy; DNA Damage; Gamma Rays; Genes, p53; Head and Neck Neoplasms; Humans; Hyperthermia, Induced; Mice; Mice, Inbred BALB C; Mice, Nude; Micronucleus Tests; Neoplasm Proteins; Paclitaxel; Radiation-Sensitizing Agents; Tirapazamine; Triazines; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2003 |
Tumor distribution of bromodeoxyuridine-labeled cells is strongly dose dependent.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Dose-Response Relationship, Drug; Female; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Transplantation, Heterologous; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2003 |
Pretreatment proliferation parameters do not add predictive power to clinical factors in cervical cancer treated with definitive radiation therapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Apoptosis; Bromodeoxyuridine; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cell Division; Disease-Free Survival; Female; Flow Cytometry; Humans; Immunoenzyme Techniques; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Prospective Studies; Radiation-Sensitizing Agents; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms | 2003 |
Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice.
Topics: 4-Nitroquinoline-1-oxide; Animals; Bromodeoxyuridine; Carcinogens; Carcinoma, Papillary; Carcinoma, Squamous Cell; Cyclin-Dependent Kinase Inhibitor p16; Disease Models, Animal; ErbB Receptors; Esophageal Neoplasms; Female; Immunoenzyme Techniques; Keratin-14; Keratins; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mouth Neoplasms; Neoplasm Invasiveness; Tongue Neoplasms | 2004 |
The expressions of p21 and pRB may be good indicators for the sensitivity of esophageal squamous cell cancers to CPT-11: Cell proliferation activity correlates with the effect of CPT-11.
Topics: Adenovirus E1A Proteins; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Bromodeoxyuridine; Camptothecin; Carcinoma, Squamous Cell; Carrier Proteins; Cell Cycle; Cell Cycle Proteins; Cell Division; DNA Topoisomerases, Type I; Enzyme-Linked Immunosorbent Assay; Esophageal Neoplasms; Gene Expression Profiling; Humans; Immunohistochemistry; Irinotecan; Nuclear Proteins; Proto-Oncogene Proteins p21(ras); Repressor Proteins; Tumor Cells, Cultured | 2004 |
Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Topics: Animals; Borohydrides; Boron; Boron Neutron Capture Therapy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Isotopes; Mice; Micronucleus Tests; Organophosphorus Compounds; Sulfhydryl Compounds; Tumor Stem Cell Assay | 2004 |
E2F6: a member of the E2F family that does not modulate squamous differentiation.
Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Differentiation; Cell Proliferation; Cell Separation; Cells, Cultured; Coloring Agents; DNA, Complementary; E2F6 Transcription Factor; Flow Cytometry; Genes, Reporter; Humans; Keratinocytes; Microscopy, Fluorescence; Protein Isoforms; Protein Structure, Tertiary; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factors; Transfection | 2004 |
Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation.
Topics: Animals; Antimetabolites, Antineoplastic; Blotting, Western; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; Down-Regulation; Gene Silencing; Humans; In Situ Nick-End Labeling; Mice; Mice, Nude; Models, Genetic; Mouth Neoplasms; Plasmids; Proteasome Inhibitors; RNA Interference; RNA, Small Interfering; S-Phase Kinase-Associated Proteins; Time Factors; Transfection; Tumor Suppressor Proteins | 2005 |
The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclic N-Oxides; Female; Fluorescent Antibody Technique; Hyperthermia, Induced; Mice; Mice, Inbred C3H; Micronucleus Tests; Neoplasm Transplantation; Neoplasms; Quinoxalines; Tirapazamine; Triazines | 2005 |
Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model.
Topics: Animals; Apoptosis; Body Weight; Boron Compounds; Boron Neutron Capture Therapy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Female; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; Neoplasm Transplantation; Phenylalanine; Transplantation, Heterologous | 2006 |
Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development.
Topics: Animals; Animals, Newborn; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cattle; Cell Culture Techniques; Cell Proliferation; Female; Humans; Hyperplasia; Inflammation; Keratinocytes; Keratins; Mice; Mice, Transgenic; Neovascularization, Pathologic; Polymerase Chain Reaction; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Skin Neoplasms; Tetradecanoylphorbol Acetate; Up-Regulation | 2006 |
The usefulness of a continuous administration of tirapazamine combined with reduced dose-rate irradiation using {gamma}-rays or reactor thermal neutrons.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Survival; Fluorescent Antibody Technique; Gamma Rays; Hyperthermia, Induced; Infusions, Parenteral; Mice; Mice, Inbred C3H; Micronucleus Tests; Neoplasm Transplantation; Neutrons; Radiation-Sensitizing Agents; Radiotherapy Dosage; Skin Neoplasms; Tirapazamine; Treatment Outcome; Triazines | 2006 |
The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-(10)B (GB-10) as (10)B-carriers for boron neutron capture therapy.
Topics: Animals; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Drug Carriers; Liposomes; Mice; Micronucleus Tests; Polyethylene Glycols; Sulfhydryl Compounds; Transferrin | 2006 |
Antitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Bromodeoxyuridine; Calcitriol; Carcinoma, Squamous Cell; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; DNA, Neoplasm; Ergocalciferols; MAP Kinase Kinase Kinase 1; MAP Kinase Kinase Kinases; Mice; Mice, Inbred C3H; Mitogen-Activated Protein Kinase 3; Oncogene Protein v-akt; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction | 2006 |
Overexpression of the opioid growth factor receptor downregulates cell proliferation of human squamous carcinoma cells of the head and neck.
Topics: Aged; Antibodies; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Count; Cell Line, Tumor; Cell Proliferation; Clone Cells; DNA, Neoplasm; Down-Regulation; Enkephalin, Methionine; Gene Expression; Head and Neck Neoplasms; Humans; Kinetics; Male; Protein Binding; Protein Transport; Receptors, Opioid | 2007 |
DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
Topics: Adult; Aged; Aged, 80 and over; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Proliferation; DNA, Neoplasm; Female; Flow Cytometry; Fluorescent Antibody Technique; Head and Neck Neoplasms; Humans; Male; Middle Aged; Ploidies; Radiation-Sensitizing Agents | 2008 |
Inhibition of repair of radiation-induced damage by mild temperature hyperthermia, referring to the effect on quiescent cell populations.
Topics: Androstadienes; Animals; Antineoplastic Agents; Bromodeoxyuridine; Caffeine; Carcinoma, Squamous Cell; Cell Proliferation; Combined Modality Therapy; Female; Gamma Rays; Hyperthermia, Induced; Indicators and Reagents; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Radiation Injuries, Experimental; Temperature; Transplantation, Heterologous; Tumor Cells, Cultured; Wortmannin | 2007 |
Radiobiologic significance of response of intratumor quiescent cells in vivo to accelerated carbon ion beams compared with gamma-rays and reactor neutron beams.
Topics: Animals; Bromodeoxyuridine; Carbon; Carcinoma, Squamous Cell; Cell Proliferation; Fluorescent Antibody Technique; Gamma Rays; Linear Energy Transfer; Mice; Mice, Inbred C3H; Micronucleus Tests; Neutrons; Radiation Tolerance; Radiobiology; Xenograft Model Antitumor Assays | 2008 |
Intra-arterial 5-bromodeoxyuridine and x-ray therapy.
Topics: Bromodeoxyuridine; Carbon Isotopes; Carcinoma, Squamous Cell; Carotid Arteries; DNA, Neoplasm; Facial Neoplasms; Female; Head and Neck Neoplasms; Humans; Infusions, Parenteral; Injections, Intra-Arterial; Male; Methotrexate; Mouth Neoplasms; Radiation-Sensitizing Agents; Uterine Cervical Neoplasms | 1967 |
Keratinization and the effect of vitamin A in aggregates of a squamous carcinoma cell line NBT II.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Aggregation; Cell Differentiation; Cell Line; Cytarabine; DNA, Neoplasm; Keratins; Mitosis; Rats; Urinary Bladder Neoplasms; Vitamin A | 1980 |
Epidermal growth factor promoted changes in the triton-insoluble cytoskeletal matrix from human epidermal carcinoma cells: effect of bromodeoxyuridine.
Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Line; Cytoplasm; Epidermal Growth Factor; Humans; Mercaptoethanol; Octoxynol; Polyethylene Glycols; Proteins; Sodium Dodecyl Sulfate; Solubility; Urea | 1983 |
[Treatment of maxillary cancer].
Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorouracil; Humans; Infusions, Intra-Arterial; Maxillary Sinus; Paranasal Sinus Neoplasms; Prognosis; Radiotherapy Dosage | 1984 |
Lymphocyte reactivity in patients with cancer of the oral cavity measured by sister chromatid differential staining.
Topics: Aged; Azure Stains; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Crossing Over, Genetic; Female; Humans; Lymphocyte Activation; Lymphocytes; Male; Middle Aged; Mouth Neoplasms; Sister Chromatid Exchange | 1983 |
Nucleolar organizer regions in tongue carcinomas induced in rats: comparison with DNA cytofluorometric analysis.
Topics: 4-Nitroquinoline-1-oxide; Aneuploidy; Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Diploidy; DNA, Neoplasm; Epithelium; Flow Cytometry; Male; Nucleolus Organizer Region; Papilloma; Polyploidy; Rats; Rats, Sprague-Dawley; Silver; Staining and Labeling; Tongue Neoplasms | 1994 |
Effect of endogenous and exogenous EGF on the growth of EGF receptor-hyperproducing human squamous cell carcinoma implanted in nude mice.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Epidermal Growth Factor; ErbB Receptors; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitosis; Neoplasm Transplantation; Transplantation, Heterologous | 1995 |
In vivo labelling with halogenated pyrimidines of squamous cell carcinomas and adjacent non-involved mucosa of head and neck region.
Topics: Biomarkers, Tumor; Biopsy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Epithelial Cells; Head and Neck Neoplasms; Humans; Idoxuridine; Leydig Cell Tumor; Mucous Membrane; S Phase | 1995 |
Chemical skin carcinogenesis is prevented in mice by the induced expression of a TGF-beta related transgene.
Topics: Animals; Bone Morphogenetic Proteins; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Epidermis; Methylnitronitrosoguanidine; Mice; Mice, Transgenic; Papilloma; Proteins; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta | 1995 |
Stimulatory effects of hepatocyte growth factor on normal and neoplastic human bronchial epithelial cells.
Topics: Adenocarcinoma; Adult; Aged; Base Sequence; Blotting, Western; Bromodeoxyuridine; Bronchi; Carcinoma, Squamous Cell; Cell Division; Cells, Cultured; Chemotaxis; DNA Primers; Epithelial Cells; Epithelium; Female; Fibroblasts; Hepatocyte Growth Factor; Humans; Lung Diseases; Lung Neoplasms; Lung Transplantation; Male; Middle Aged; Molecular Sequence Data; Neoplasm Invasiveness; Polymerase Chain Reaction; Proto-Oncogene Proteins c-met; Proto-Oncogenes; Receptor Protein-Tyrosine Kinases; Tumor Cells, Cultured | 1995 |
Cytokinetic studies of oral cancer cells using bromodeoxyuridine labelling in relation to factors influencing prognosis.
Topics: Adult; Aged; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Female; Humans; Immunohistochemistry; Male; Microscopy, Fluorescence; Middle Aged; Mitotic Index; Mouth Neoplasms; Prognosis | 1995 |
Tumor cell kinetics in elderly patients with cervical cancer.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aneuploidy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; DNA, Neoplasm; Female; Flow Cytometry; Humans; Kinetics; Middle Aged; Neoplasm Staging; Staining and Labeling; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1993 |
Use of in situ detection of histone mRNA in the assessment of epidermal proliferation: comparison with the Ki67 antigen and BrdU incorporation.
Topics: Bowen's Disease; Bromodeoxyuridine; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Histones; Humans; In Situ Hybridization; In Vitro Techniques; Keratosis; Ki-1 Antigen; Ki-67 Antigen; Mitotic Index; Neoplasm Proteins; Nuclear Proteins; Psoriasis; RNA, Messenger; Skin; Skin Neoplasms | 1995 |
p53 status of head and neck cancer: relation to biological characteristics and outcome of radiotherapy.
Topics: Aneuploidy; Biopsy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Disease-Free Survival; DNA, Neoplasm; Flow Cytometry; Genes, p53; Head and Neck Neoplasms; Humans; Immunohistochemistry; Kinetics; Neoplasm Recurrence, Local; Predictive Value of Tests; Treatment Outcome; Tumor Suppressor Protein p53 | 1995 |
Influence of sampling time on assessment of potential doubling time.
Topics: Adenocarcinoma; Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; DNA, Neoplasm; Female; Flow Cytometry; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Neoplasm Transplantation; Prostatic Neoplasms; Rats; Rats, Inbred F344; Reproducibility of Results; S Phase; Specimen Handling; Time Factors | 1994 |
A comparison of cellular proliferation markers in squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Biomarkers, Tumor; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Neoplasm Proteins; Nuclear Proteins; Ploidies; Prognosis; Proliferating Cell Nuclear Antigen; S Phase | 1994 |
The response of quiescent cell populations in murine solid tumors to irradiation with fast neutrons.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Nucleus; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Radiation; Fast Neutrons; Female; Fluorescent Antibody Technique; Linear Energy Transfer; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Radiation Tolerance; Radiotherapy, High-Energy | 1994 |
Assessment of bromodeoxyuridine-labeled S-phase cells in experimentally induced precancerous lesions in the rat's tongue.
Topics: 4-Nitroquinoline-1-oxide; Animals; Bromodeoxyuridine; Carcinoma in Situ; Carcinoma, Squamous Cell; Cell Count; Cell Division; Epithelium; Hyperplasia; Leukoplakia, Oral; Male; Neoplasm Invasiveness; Papilloma; Precancerous Conditions; Rats; Rats, Sprague-Dawley; S Phase; Tongue Neoplasms | 1994 |
Cellular kinetics and lectin distribution in hamster buccal carcinomas.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Cell Transformation, Neoplastic; Cheek; Cricetinae; Epithelium; Hyperplasia; Immunoenzyme Techniques; Lectins; Male; Mouth Mucosa; Mouth Neoplasms; Papilloma; Protein Binding | 1994 |
Prospective evaluation of cell kinetics in head and neck squamous carcinoma: the relationship to tumour factors and survival.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Aneuploidy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Count; Cell Division; Chi-Square Distribution; DNA, Neoplasm; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mitotic Index; Neoplasm Staging; Prognosis; Prospective Studies; S Phase; Survival Analysis; Survival Rate | 1994 |
Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer.
Topics: Aged; Aneuploidy; Biopsy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cell Transformation, Neoplastic; Diploidy; DNA, Neoplasm; Female; Humans; Injections; Male; Middle Aged; Oropharyngeal Neoplasms; Prospective Studies; S Phase; Time Factors | 1994 |
Correlation between p53 gene expression and tumor-cell proliferation in oropharyngeal cancer.
Topics: Aged; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; DNA, Neoplasm; Female; Flow Cytometry; Gene Expression; Genes, p53; Humans; Immunohistochemistry; Male; Middle Aged; Oropharyngeal Neoplasms; Prospective Studies; S Phase; Tumor Suppressor Protein p53 | 1994 |
Application of in vitro bromodeoxyuridine labeling of oral cancers.
Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Cell Transformation, Neoplastic; Epithelium; Humans; Immunoenzyme Techniques; Mouth Neoplasms; Papilloma; S Phase; Tumor Cells, Cultured | 1993 |
Cell kinetic analysis of murine squamous cell carcinomas: a comparison of single versus double labelling using flow cytometry and immunohistochemistry.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Cell Size; DNA, Neoplasm; Female; Flow Cytometry; Histocytochemistry; Mice; Mice, Inbred C3H; Mouth Neoplasms; Regression Analysis; S Phase; Thymidine; Time Factors; Tumor Cells, Cultured; Vaginal Neoplasms | 1993 |
[Determination of potential doubling time using in vitro continuous labeling method with bromodeoxyuridine: estimation in head and neck squamous cell carcinoma].
Topics: Brachytherapy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Count; Cell Division; Head and Neck Neoplasms; Humans; Tumor Cells, Cultured | 1993 |
Estimation of proliferative activity of experimental tongue carcinoma in rats. Immunohistochemical and DNA cytofluorometric analysis.
Topics: 4-Nitroquinoline-1-oxide; Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Diploidy; Epithelium; Flow Cytometry; G2 Phase; Immunohistochemistry; Male; Mitosis; Papilloma; Polyploidy; Rats; Rats, Sprague-Dawley; S Phase; Tongue Neoplasms | 1993 |
Cell kinetics study of upper aerodigestive tract squamous cell carcinoma using bromodeoxyuridine.
Topics: Adult; Aged; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Female; Humans; Immunohistochemistry; Male; Middle Aged; Mouth Neoplasms; Otorhinolaryngologic Neoplasms | 1993 |
Analysis of the results of combined therapy for maxillary carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Maxillary Sinus Neoplasms; Radiotherapy Dosage; Salvage Therapy; Survival Rate | 1993 |
Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy.
Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Flow Cytometry; Head and Neck Neoplasms; Humans; Immunohistochemistry; Injections; Multivariate Analysis; Ploidies; Radiotherapy | 1995 |
Radiation induced G1-block and p53 status in six human cell lines.
Topics: Antimetabolites; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cell Cycle Proteins; Cell Division; Cell Line, Transformed; Culture Media, Serum-Free; DNA Damage; DNA, Neoplasm; Fibroblasts; G1 Phase; Humans; Male; Melanoma; Middle Aged; Mutation; Radiotherapy Dosage; Resting Phase, Cell Cycle; S Phase; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1995 |
Experimental study of combined hyperthermic and photodynamic therapy on carcinoma in the mouse.
Topics: Aluminum Silicates; Animals; Antimetabolites; Bromodeoxyuridine; Carcinoma, Squamous Cell; Combined Modality Therapy; Hematoporphyrin Photoradiation; Hematoporphyrins; Hyperthermia, Induced; Laser Therapy; Male; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Necrosis; Neodymium; Photosensitizing Agents; Skin Neoplasms; Yttrium | 1996 |
Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours.
Topics: Antibody Specificity; Antigens, Neoplasm; Biomarkers, Tumor; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Flow Cytometry; Head and Neck Neoplasms; Humans; Immunohistochemistry; Ki-67 Antigen; Neoplasm Proteins; Nuclear Proteins; Population; Radiotherapy | 1996 |
Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks.
Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Disease-Free Survival; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Mouth Neoplasms; Multivariate Analysis; Neoplasm Staging; Oropharyngeal Neoplasms; Prospective Studies; Radiotherapy Dosage; Time Factors; Treatment Failure | 1996 |
Argyrophilic nucleolar organizer regions, bromodeoxyuridine labelling index and DNA ploidy in squamous cell carcinoma of the uterine cervix.
Topics: Adult; Aged; Aneuploidy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; DNA, Neoplasm; Female; Humans; Middle Aged; Nucleolus Organizer Region; Prognosis; Silver Staining; Uterine Cervical Neoplasms | 1996 |
Comparison of mathematical formulas used for estimation of DNA synthesis time of bromodeoxyuridine-labelled cell populations with different proliferative characteristics.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cells, Cultured; DNA; Endometrial Neoplasms; Female; Fibroblasts; Flow Cytometry; Head and Neck Neoplasms; Humans; In Vitro Techniques; Kinetics; Lung; Mathematical Computing; Mice; Mice, Inbred BALB C; Mice, Nude; Sampling Studies; Time Factors; Tissue Transplantation; Tumor Cells, Cultured | 1996 |
Inhibitory effects of dietary protocatechuic acid and costunolide on 7,12-dimethylbenz[a]anthracene-induced hamster cheek pouch carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antimetabolites, Antineoplastic; Bromodeoxyuridine; Carcinogens; Carcinoma, Squamous Cell; Cheek; Cricetinae; Hydroxybenzoates; Male; Mesocricetus; Mouth Neoplasms; Neoplasm Proteins; Neoplasms, Experimental; Nucleolus Organizer Region; Papilloma; Sesquiterpenes; Telomerase | 1997 |
Reduction of hypoxic cells in solid tumours induced by mild hyperthermia: special reference to differences in changes in the hypoxic fraction between total and quiescent cell populations.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Cell Hypoxia; Cell Survival; Hyperthermia, Induced; Kinetics; Mice; Mice, Inbred C3H; Micronuclei, Chromosome-Defective; Micronucleus Tests; Regression Analysis | 1997 |
Tumour cell kinetics as prognostic factor in surgically-treated-non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Bromodeoxyuridine; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Division; Flow Cytometry; Humans; Lung Neoplasms; Middle Aged; Prognosis; S Phase; Survival Rate | 1997 |
Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromodeoxyuridine; Carcinogens; Carcinoma, Squamous Cell; Cell Division; Cells, Cultured; Cocarcinogenesis; Female; Genes, ras; Genotype; Immunohistochemistry; Keratinocytes; Mice; Mice, Inbred BALB C; Mirex; Mutation; Nitrosourea Compounds; Papilloma; S Phase; Skin Neoplasms; Tetradecanoylphorbol Acetate | 1997 |
Augmentation in chemosensitivity of intratumor quiescent cells by combined treatment with nicotinamide and mild hyperthermia.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Cell Hypoxia; Cisplatin; Drug Resistance, Neoplasm; Hyperthermia, Induced; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Micronucleus Tests; Microscopy, Fluorescence; Neoplasm Transplantation; Niacinamide; Sarcoma, Experimental; Vasodilator Agents | 1997 |
Effects of bioreductive agents, tirapazamine and mitomycin C, on quiescent cell populations in solid tumors, evaluated by micronucleus assay.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Cobalt Radioisotopes; Cytochalasin B; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Gamma Rays; Mice; Mice, Inbred C3H; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mitomycin; Mitotic Index; Tirapazamine; Triazines | 1997 |
Inhibitory effect of black tea on the growth of established skin tumors in mice: effects on tumor size, apoptosis, mitosis and bromodeoxyuridine incorporation into DNA.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Bromodeoxyuridine; Carcinoma, Squamous Cell; DNA; Female; Keratoacanthoma; Mice; Mitosis; Papilloma; Skin Neoplasms; Tea; Ultraviolet Rays | 1997 |
Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Flow Cytometry; Glioblastoma; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Mice; Mice, Nude; Microscopy; Radiation-Sensitizing Agents; Regional Blood Flow; Transplantation, Heterologous | 1998 |
Responses of total and quiescent cell populations in solid tumors to boron and gadolinium neutron capture reaction using neutrons with two different energy spectra.
Topics: Animals; Borohydrides; Boron; Boron Compounds; Boron Neutron Capture Therapy; Bromodeoxyuridine; Cadmium Radioisotopes; Carcinoma, Squamous Cell; Contrast Media; Cytochalasin B; Dose-Response Relationship, Radiation; Female; Fluorescent Antibody Technique, Indirect; Gadolinium; Gadolinium DTPA; Injections, Intraperitoneal; Isotopes; Mice; Mice, Inbred C3H; Micronucleus Tests; Neoplasm Transplantation; Phenylalanine; Radiation-Sensitizing Agents; Sulfhydryl Compounds; Tumor Cells, Cultured | 1998 |
[Immunohistological studies on growth potential of head and neck carcinomas].
Topics: Adult; Aged; Biomarkers, Tumor; Bromodeoxyuridine; Carcinoma, Squamous Cell; ErbB Receptors; Female; Head and Neck Neoplasms; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Middle Aged; Prognosis; S Phase | 1998 |
Esophageal and gastric cardia epithelial cell proliferation in northern Chinese subjects living in a high-incidence area.
Topics: Adenocarcinoma; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cardia; Cell Division; China; Epithelial Cells; Esophageal Neoplasms; Esophagus; Humans; Immunohistochemistry; Incidence; Ki-67 Antigen; Proliferating Cell Nuclear Antigen; Stomach Neoplasms | 1997 |
Novel S100 proteins in human esophageal epithelial cells: CAAF1 expression is associated with cell growth arrest.
Topics: Amino Acid Sequence; Animals; Antigens, Differentiation; Base Sequence; Bromodeoxyuridine; Calcium-Binding Proteins; Calgranulin A; Calgranulin B; Carcinoma, Squamous Cell; Cell Division; Cells, Cultured; Cloning, Molecular; DNA, Complementary; Epithelial Cells; Epithelium; Esophageal Neoplasms; Esophagus; Fibroblasts; Gene Expression; Humans; Mice; Molecular Sequence Data; Neutrophils; S100 Proteins; S100A12 Protein | 1998 |
The anti-tumor effect of photodynamic therapy evaluated by bromodeoxyuridine immunohistochemistry.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Hematoporphyrin Photoradiation; Immunohistochemistry; Lasers; Male; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Statistics, Nonparametric | 1998 |
Comparison of bromodeoxyuridine labeling indices of smears and sections from mouse NR-S1 tumor.
Topics: Animals; Antimetabolites, Antineoplastic; Bromodeoxyuridine; Carcinoma, Squamous Cell; Immunohistochemistry; Mice; Neoplasm Transplantation; Paraffin Embedding | 1998 |
Response of quiescent and total tumor cells in solid tumors to neutrons with various cadmium ratios.
Topics: Animals; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Bromodeoxyuridine; Cadmium Radioisotopes; Carcinoma, Squamous Cell; Cell Division; Dose-Response Relationship, Radiation; Energy Transfer; Female; Gamma Rays; Mice; Mice, Inbred C3H; Micronucleus Tests; Phenylalanine; Relative Biological Effectiveness; Sulfhydryl Compounds | 1998 |
Cell kinetics of head and neck cancers.
Topics: Biopsy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; DNA, Neoplasm; G2 Phase; Head and Neck Neoplasms; Humans; Idoxuridine; Kinetics; Lymphoma; Mitotic Index; S Phase; Time Factors | 1995 |
Enhanced antitumor efficacy of cisplatin in combination with ALRT1057 (9-cis retinoic acid) in human oral squamous carcinoma xenografts in nude mice.
Topics: Alitretinoin; Animals; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Mice; Mice, Nude; Mouth Neoplasms; Neoplasm Transplantation; Receptors, Retinoic Acid; Retinoid X Receptors; Transcription Factors; Transplantation, Heterologous; Tretinoin | 1996 |
Proliferative potential of canine oral epulides and malignant neoplasms assessed by bromodeoxyuridine labeling.
Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Bromodeoxyuridine; Carcinoma, Squamous Cell; Dog Diseases; Dogs; Female; Fibrosarcoma; Gingival Diseases; Gingival Neoplasms; Male; Melanoma; Mitotic Index; Mouth Neoplasms | 1999 |
Tumour cell kinetics as a prognostic factor in squamous cell carcinoma of the cervix treated with radiotherapy.
Topics: Adult; Age Factors; Aged; Analysis of Variance; Aneuploidy; Antimetabolites; Brachytherapy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Diploidy; DNA, Neoplasm; Female; Flow Cytometry; Forecasting; Humans; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Radiotherapy Dosage; S Phase; Survival Rate; Uterine Cervical Neoplasms | 1999 |
Tumor proliferation and apoptosis in human uterine cervix carcinoma I: correlations between variables.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aneuploidy; Antimetabolites; Apoptosis; Biopsy; Bromodeoxyuridine; Carcinoma; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cell Division; Diploidy; Disease Progression; Female; Flow Cytometry; Forecasting; Humans; Middle Aged; Mitosis; Neoplasm Staging; Prospective Studies; S Phase; Treatment Outcome; Uterine Cervical Neoplasms | 1999 |
Repair of potentially lethal damage by total and quiescent cells in solid tumors following a neutron capture reaction.
Topics: Animals; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Cytochalasin B; DNA Damage; Dose-Response Relationship, Radiation; Female; Gamma Rays; Mice; Mice, Inbred C3H; Micronucleus Tests; Neoplasm Transplantation; Phenylalanine; Sensitivity and Specificity; Sulfhydryl Compounds; Tumor Cells, Cultured | 1999 |
Interrelationship of proliferation and hypoxia in carcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Cell Hypoxia; Female; Humans; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Uterine Cervical Neoplasms | 2000 |
Alteration of sensitivity of intratumor quiescent and total cells to gamma-rays following thermal neutron irradiation with or without 10B-compound.
Topics: Animals; Boron Neutron Capture Therapy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Dose-Response Relationship, Radiation; Female; Gamma Rays; Mice; Mice, Inbred C3H; Micronucleus Tests; Neoplasms, Experimental; Radiation Tolerance; Radiation-Sensitizing Agents; Radiobiology | 2000 |
In vitro response of human gingival epithelial S-G cells to resveratrol.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antioxidants; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Count; Cell Division; Cell Line; Cell Survival; Coloring Agents; Cyclophosphamide; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Fibroblasts; Gingiva; Humans; Indicators and Reagents; Keratinocytes; Neutral Red; Oxazines; Resveratrol; Stilbenes; Tongue Neoplasms; Xanthenes | 2000 |
Reoxygenation in quiescent and total intratumor cells following thermal neutron irradiation with or without (10)B-compound-compared with that after gamma-ray irradiation.
Topics: Animals; Antimetabolites, Antineoplastic; Boron; Boron Neutron Capture Therapy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Cell Hypoxia; Cell Survival; Dose-Response Relationship, Radiation; Female; Fluorescent Antibody Technique, Indirect; Isotopes; Linear Energy Transfer; Mice; Mice, Inbred C3H; Micronucleus Tests; Oxygen Consumption; Radiation-Sensitizing Agents; Radiobiology; Regression Analysis | 1999 |
Usefulness of tirapazamine as a combined agent in chemoradiation and thermo-chemoradiation therapy at mild temperatures: reference to the effect on intratumor quiescent cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Radiation; Doxorubicin; Hyperthermia, Induced; Mice; Mice, Inbred C3H; Micronucleus Tests; Mitomycin; Radiation-Sensitizing Agents; Tirapazamine; Triazines | 2000 |
Aberrant cell cycle progression contributes to the early-stage accelerated carcinogenesis in transgenic epidermis expressing the dominant negative TGFbetaRII.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromodeoxyuridine; Carcinogens; Carcinoma, Squamous Cell; Carrier Proteins; Cell Cycle; Cell Cycle Proteins; Cell Transformation, Neoplastic; Centrosome; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p27; Epidermal Cells; Gene Expression; Mice; Mice, Transgenic; Microtubule-Associated Proteins; Mitosis; Papilloma; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Tetradecanoylphorbol Acetate; Time Factors; Tumor Suppressor Proteins | 2000 |
Enhancement of the photodynamic antitumor effect by streptococcal preparation OK-432 in the mouse carcinoma.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Carcinoma, Squamous Cell; Combined Modality Therapy; Immunohistochemistry; Male; Mice; Mice, Inbred C3H; Necrosis; Neoplasm Transplantation; Neutrophils; Photochemotherapy; Picibanil; Time Factors; Treatment Outcome; Tumor Cells, Cultured | 2000 |
Change in oxygenation status in intratumour total and quiescent cells following gamma-ray irradiation, tirapazamine administration, cisplatin injection and bleomycin treatment.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Bleomycin; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Hypoxia; Cisplatin; Cytochalasin B; Injections; Mice; Micronucleus Tests; Tirapazamine; Triazines; Tumor Cells, Cultured | 2000 |
Is there a future for cell kinetic measurements using IdUrd or BdUrd?
Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; DNA, Neoplasm; Esophageal Neoplasms; Follow-Up Studies; Forecasting; Head and Neck Neoplasms; Humans; Idoxuridine; Multicenter Studies as Topic; Neoplasm Staging; Ploidies; Time Factors | 2001 |
Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Aneuploidy; Antibodies, Monoclonal; Antimetabolites; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Count; Cell Cycle; Cell Differentiation; Chromogenic Compounds; Coloring Agents; Diploidy; Female; Flow Cytometry; Forecasting; Gene Expression Regulation, Neoplastic; Genes, p53; Head and Neck Neoplasms; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Statistics, Nonparametric; Survival Rate; Tumor Suppressor Protein p53 | 2001 |
Proliferative capacity in head and neck cancer.
Topics: Antimetabolites, Antineoplastic; Bromodeoxyuridine; Carcinoma, Squamous Cell; DNA, Neoplasm; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Injections, Intravenous; Male; Middle Aged; Mitotic Index; Neoplasm Staging; Ploidies; Prospective Studies; Radiotherapy Dosage | 2001 |
Calcipotriol inhibits autocrine phosphorylation of EGF receptor in a calcium-dependent manner, a possible mechanism for its inhibition of cell proliferation and stimulation of cell differentiation.
Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Antineoplastic Agents; Apoptosis; Autocrine Communication; Blotting, Western; Bromodeoxyuridine; Calcitriol; Calcium; Carcinoma, Squamous Cell; Cell Differentiation; Cell Division; Cell Line; ErbB Receptors; Fluorescent Dyes; Humans; Keratinocytes; Phosphorylation; Proliferating Cell Nuclear Antigen; Protein Precursors; Proteins; Shc Signaling Adaptor Proteins; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1; Tetrazolium Salts; Thiazoles | 2001 |
Radiosensitization effect by combination with paclitaxel in vivo, including the effect on intratumor quiescent cells.
Topics: Animals; Apoptosis; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Survival; Humans; Mice; Mice, Inbred C3H; Micronucleus Tests; Neoplasms; Paclitaxel; Radiation Tolerance; Radiation-Sensitizing Agents; Radiobiology; Radiotherapy Dosage; Time Factors; Tirapazamine; Triazines | 2001 |
Application of the membrane filter technique to bromodeoxyuridine immunochemistry for exfoliative cytology.
Topics: Adenocarcinoma; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cytological Techniques; Humans; Immunochemistry; Jaw Neoplasms; Membranes, Artificial; Mouth Neoplasms; Staining and Labeling; Tumor Cells, Cultured | 2001 |
Evaluation of the potential of p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, referring to the effect on intratumor quiescent cells.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Boranes; Boron Neutron Capture Therapy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Combined Modality Therapy; Cytochalasin B; Drug Screening Assays, Antitumor; Fluorescent Antibody Technique, Indirect; Hindlimb; Hyperthermia, Induced; Injections, Intraperitoneal; Interphase; Lymphoma; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Micronucleus Tests; Molecular Structure; Neutrons; Phenylalanine; Radiation-Sensitizing Agents; Radiometry; Tirapazamine; Triazines | 2001 |
Evaluation of apoptosis and micronucleation induced by reactor neutron beams with two different cadmium ratios in total and quiescent cell populations within solid tumors.
Topics: Animals; Apoptosis; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Bromodeoxyuridine; Cadmium; Carcinoma, Squamous Cell; Cytochalasin B; Fluorescent Antibody Technique; Lymphoma; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Micronucleus Tests; Neoplasms; Neutrons; Phenylalanine; Radiation Tolerance; Radiation-Sensitizing Agents; Radiobiology; Radioisotopes; Relative Biological Effectiveness; Sarcoma, Experimental; Sulfhydryl Compounds; Tumor Cells, Cultured | 2001 |
Cell kinetic changes in human squamous cell carcinomas during radiotherapy studied using the in vivo administration of two halogenated pyrimidines.
Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Feasibility Studies; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Idoxuridine; Male; Nucleic Acid Synthesis Inhibitors; Treatment Outcome | 2002 |
The effects of methyl mercaptan on epithelial cell growth and proliferation.
Topics: Analysis of Variance; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Count; Cell Division; Cell Survival; Cells, Cultured; Epithelial Cells; Fibroblasts; Gingiva; Halitosis; Humans; KB Cells; L-Lactate Dehydrogenase; Statistics as Topic; Sulfhydryl Compounds; Time Factors; Tumor Cells, Cultured | 2002 |
The effects of "BAR" therapy on oral malignant tumors.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Bromodeoxyuridine; Carcinoma, Squamous Cell; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Maxillary Neoplasms; Middle Aged; Mouth Floor; Mouth Neoplasms; Radiation-Sensitizing Agents; Radiotherapy Dosage; Tongue Neoplasms | 1978 |
Combined surgery, radiotherapy and regional chemotherapy in carcinoma of the maxillary sinus.
Topics: Bromodeoxyuridine; Carcinoma; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Fluorouracil; Humans; Injections, Intra-Arterial; Maxillary Sinus; Methods; Paranasal Sinus Neoplasms | 1978 |
In vivo labelling of human tumours with bromodeoxyuridine: a histopathologist's view.
Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Count; Flow Cytometry; Humans; Mitosis; Neoplasms | 1992 |
Experimental and clinical evaluation by flow cytometry for the mechanism of combination therapy (cisplatin and peplomycin).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cisplatin; Flow Cytometry; G2 Phase; Humans; In Vitro Techniques; Male; Maxillary Neoplasms; Middle Aged; Peplomycin; S Phase; Tumor Cells, Cultured | 1992 |
Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.
Topics: Animals; Autoradiography; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cell Death; Cell Division; DNA, Neoplasm; Female; Humans; Leg; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nasal Cavity; Neoplasm Transplantation; Nose Neoplasms; Software; Thymidine; Transplantation, Heterologous; Tritium; Tumor Cells, Cultured | 1992 |
Reversibility of carcinogen-induced rat forestomach basal cell hyperplasia is due to squamous cell differentiation.
Topics: Animals; Bromodeoxyuridine; Butylated Hydroxyanisole; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Differentiation; Cell Transformation, Neoplastic; Gastric Mucosa; Hyperplasia; Image Processing, Computer-Assisted; Male; Methylnitronitrosoguanidine; Rats; Rats, Inbred F344; Stomach; Stomach Neoplasms | 1992 |
Modulation of cell cycle kinetics in human cancer with total parenteral nutrition.
Topics: Adult; Aged; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nutritional Status; Parenteral Nutrition, Total; S Phase | 1992 |
Tumour growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry.
Topics: Aneuploidy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Flow Cytometry; Head and Neck Neoplasms; Humans; Predictive Value of Tests; Prognosis; Prospective Studies; Reproducibility of Results; S Phase | 1992 |
Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck.
Topics: Aneuploidy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; DNA, Neoplasm; Flow Cytometry; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Recurrence | 1992 |
A quantitative method for evaluating bivariate flow cytometric data obtained using monoclonal antibodies to bromodeoxyuridine.
Topics: Animals; Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cells, Cultured; Chick Embryo; CHO Cells; Cricetinae; DNA; DNA, Neoplasm; Extremities; Flow Cytometry; Fluorescence; Mammary Neoplasms, Experimental; Mice; Rectal Neoplasms; Sarcoma, Experimental; Tumor Cells, Cultured | 1992 |
The use of bromodeoxyuridine cytokinetic studies as a prognostic indicator of cancer of the head and neck.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Female; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Prognosis; Staining and Labeling | 1991 |
Measurement of in vivo urological tumour cell kinetics using multiparameter flow cytometry. Preliminary study.
Topics: Aneuploidy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; DNA, Neoplasm; Flow Cytometry; Humans; Kidney Neoplasms; Kinetics; Male; Mitosis; Penile Neoplasms; Prostatic Neoplasms; S Phase; Urinary Bladder Neoplasms | 1991 |
Cell cycle parameters and DNA ploidy in colorectal carcinomas.
Topics: Adenocarcinoma; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Colorectal Neoplasms; DNA; Humans; Idoxuridine; Pilot Projects; Ploidies; S Phase; Time Factors | 1991 |
Proliferative pattern of head and neck cancer.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Male; Mice; Mice, Inbred C57BL; Nuclear Proteins; Ribonucleotide Reductases | 1991 |
In vitro bromodeoxyuridine labelling of squamous cell carcinomas of the oral cavity.
Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Fluorescent Antibody Technique; Humans; Methods; Mouth Neoplasms; Prognosis; Tumor Cells, Cultured | 1990 |
Cytokinetic investigation of lung tumors using the anti-bromodeoxyuridine (BUdR) monoclonal antibody method: comparison with DNA flow cytometric data.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Cycle; DNA, Neoplasm; Flow Cytometry; Fluorescent Antibody Technique; Humans; Interphase; Lung Neoplasms; Neoplasm Proteins; Tumor Cells, Cultured | 1990 |
Synergistic cytotoxicity and DNA strand break formation by bromodeoxyuridine and bleomycin in human tumor cells.
Topics: Algorithms; Bleomycin; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Line; DNA Damage; Drug Synergism; Humans; Hydrogen-Ion Concentration; Laryngeal Neoplasms; Tumor Cells, Cultured | 1988 |
Labelling index of gynaecological tumours assessed by bromodeoxyuridine staining in vitro using flow cytometry and histochemistry.
Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Female; Flow Cytometry; Humans; Staining and Labeling; Uterine Cervical Neoplasms | 1989 |
Clinical evaluation for the mechanism of cisplatin with bromodeoxyuridine by flow cytometry and clinico-histological study.
Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cisplatin; DNA; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Dyes; Humans; Kinetics; Male; Maxillary Neoplasms; Middle Aged; Propidium; Thiocyanates | 1989 |
[Experimental study on the effect of UFT with concomitant radiotherapy of uterine cervical cancer].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Cell Line; Combined Modality Therapy; DNA Polymerase II; Female; Fluorouracil; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Tegafur; Tumor Cells, Cultured; Uracil; Uterine Cervical Neoplasms | 1989 |
Patterns of epithelial proliferation revealed by intraperitoneal administration of bromodeoxyuridine during buccal pouch carcinogenesis in hamsters.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Cricetinae; Immunohistochemistry; Male; Mesocricetus; Mouth Neoplasms | 1989 |
A cell kinetic study of pulmonary adenocarcinoma by an immunoperoxidase procedure after bromodeoxyuridine labeling.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Division; Cell Nucleus; Female; Humans; Immunoenzyme Techniques; Kinetics; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitotic Index | 1989 |
[Immunohistochemical approach to reveal the growth potential of uterine cancers using anti-BrdU antibody and Ki-67].
Topics: Adenocarcinoma; Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Nucleus; Female; Humans; Immunohistochemistry; Mitotic Index; Uterine Cervical Neoplasms; Uterine Neoplasms | 1989 |
In vitro immunohistochemical localization of S-phase cells by a monoclonal antibody to bromodeoxyuridine.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Breast Neoplasms; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Nucleus; Head and Neck Neoplasms; Humans; Immunohistochemistry; In Vitro Techniques; Interphase; Lymphoma; Neoplasms | 1989 |
[Cell kinetic effects of cis-platinum on cancer cells in a culture system and in cases of cervical cancer using monoclonal antibody of BrdU].
Topics: Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cisplatin; Female; Flow Cytometry; Humans; In Vitro Techniques; Interphase; Uterine Cervical Neoplasms | 1989 |
Cell proliferation and differentiation in squamous cancer.
Topics: Bromodeoxyuridine; Carcinoma, Papillary; Carcinoma, Squamous Cell; Cell Differentiation; Cell Division; DNA, Neoplasm; Female; Flow Cytometry; Humans; Male | 1989 |
5-Bromo-2'-deoxyuridine incorporation into DNA in hepatic VX2 tumor-bearing rabbits.
Topics: Animals; Bone Marrow; Bromodeoxyuridine; Carcinoma, Squamous Cell; Chromatography, Gas; DNA; DNA, Neoplasm; Duodenum; Hepatic Artery; Injections, Intra-Arterial; Injections, Intravenous; Intestinal Mucosa; Liver; Liver Neoplasms; Mass Spectrometry; Neoplasm Transplantation; Rabbits; Vena Cava, Superior | 1989 |
[Experiences with FT+BrdU+radiation therapy of esophageal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Humans; Male; Middle Aged; Tegafur | 1987 |
Dynamics of bromodeoxyuridine incorporation into DNA of squamous carcinoma cells during mid and late logarithmic growth.
Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Line; DNA, Neoplasm; Models, Biological; Thymidine; Time Factors | 1988 |
Immunocytochemical detection of S-phase cells in gynecologic malignancies using anti-BrdU monoclonal antibody.
Topics: Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cystadenocarcinoma; Female; Genital Neoplasms, Female; Humans; Immunohistochemistry; Interphase; Ovarian Neoplasms; Uterine Cervical Neoplasms | 1988 |
Relationship between labeling indices of Ki-67 and BrdUrd in human malignant tumors.
Topics: Adenocarcinoma; Antigens; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Humans; Neoplasms; Nuclear Proteins | 1988 |
[In-vivo marking of human tumors using BUDR for flow-cytometry determination of kinetic cell parameters].
Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; DNA, Neoplasm; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Interphase; Male; Ovarian Neoplasms; Sarcoma | 1987 |
Potentiation of halogenated pyrimidine radiosensitizers in human carcinoma cells by beta-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran- 5,6-dione), a novel DNA repair inhibitor.
Topics: Bromodeoxycytidine; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Line; Cells, Cultured; DNA Repair; Drug Synergism; Humans; Laryngeal Neoplasms; Naphthoquinones; Radiation-Sensitizing Agents | 1987 |
[Clinical evaluation by flow cytometry in the mechanism of action of CDDP with arterial injection of bromo deoxyuridine].
Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; Cisplatin; Flow Cytometry; Humans; Injections, Intra-Arterial; Interphase; Male; Maxillary Neoplasms; Middle Aged | 1987 |
[Cytokinetic effects of anticancer drugs on a human lung cancer cell line using monoclonal antibody against bromodeoxyuridine].
Topics: Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cisplatin; DNA, Neoplasm; Flow Cytometry; Humans; Lung Neoplasms | 1986 |
Clinical evaluation of 5-bromo-5-fluoro-6-methoxy-dihydro-2'-deoxyuridine.
Topics: Adenocarcinoma; Adult; Aged; Animals; Bromodeoxyuridine; Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Colonic Neoplasms; Deoxyuridine; Dogs; Female; Floxuridine; Gallbladder Neoplasms; Gastrointestinal Neoplasms; Humans; Ileocecal Valve; Intestinal Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Rectal Neoplasms; Sarcoma; Stomach Neoplasms | 1967 |
[Treatment of malignant brain tumors by the intrathecal administration of BAR (EUdR-antimetabolite-radiation)].
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antimetabolites; Brain Neoplasms; Bromodeoxyuridine; Carcinoma, Squamous Cell; Child; Child, Preschool; Ependymoma; Female; Glioblastoma; Humans; Injections, Spinal; Male; Medulloblastoma; Meningioma; Methotrexate; Middle Aged; Mitomycins; Pinealoma; Radiation-Sensitizing Agents; Radiotherapy, High-Energy; Retinoblastoma | 1972 |
Phosphorylation of 5-bromodeoxycytidine in cells infected with herpes simplex virus.
Topics: Adult; Animals; Bromides; Bromodeoxyuridine; Carcinoma; Carcinoma, Squamous Cell; Cell Line; Cell Transformation, Neoplastic; Cricetinae; Deoxycytidine; Deoxycytidine Monophosphate; Deoxyribonucleosides; Deoxyribonucleotides; DNA; DNA, Neoplasm; Female; Humans; Kidney; Laryngeal Neoplasms; Middle Aged; Phosphorus; Phosphotransferases; Simplexvirus; Tritium; Uterine Cervical Neoplasms; Viral Plaque Assay | 1973 |
Studies on the variability of the KB cell line.
Topics: Alkaline Phosphatase; Aminopterin; Azaguanine; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Line; Chromosomes; Clone Cells; Culture Techniques; Enzyme Induction; Humans; Mercaptopurine; Mouth Neoplasms; Sulfhydryl Compounds | 1969 |